CrushSCI.com
Journal Selection & Manuscript Polishing Services
International Journal of Clinical Oncology journal cover Medicine
Back to journal directory

Review Cycle Records

International Journal of Clinical Oncology

Springer SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q2
97.6Average days
91.5Median days
30Fastest days
248Longest days
2652025 publications

Paper Review Records

All Paper Review Records

14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

136 days

Association between response to gemcitabine-based neoadjuvant therapy and efficacy of gemcitabine plus nab-paclitaxel for recurrent pancreatic ductal adenocarcinoma

AuthorsTakumi Kinomoto; Kenji Ikezawa; Kunihito Gotoh; Yugo Kai; Ryoji Takada; Takanori Masumoto; Masaki Kawabata; Hiroki Kishimoto; Kana Ito; Makiko Urabe; Kaori Mukai; Tasuku Nakabori; Minoru Shigekawa; Hirofumi Akita; Hidenori Takahashi; Shogo Kobayashi; Kazuyoshi Ohkawa

Affiliations1. Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan; 2. Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Amagasaki, Japan; 3. Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan; 4. Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan; 5. Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan

Source PDF DOI Publisher page
53 days

High therapeutic efficacy of triplet therapy in unresectable or metastatic colorectal cancer and its optimal application strategies

AuthorsHiroki Sakuyama; Hiroyuki Okuyama; Yoriyuki Tahara; Sena Tsukamoto; Ikuhiro Kita; Kotone Nomura; Akitsu Murakami; Yoshihiro Okita; Hironaga Satake; Takeshi Kato; Akihito Tsuji

Affiliations1. Department of Medical Oncology, Kagawa University Hospital, Miki, Japan; 2. Department of Medical Oncology, Japanese Red Cross Society Himeji Hospital, Himeji, Japan; 3. Department of Medical Oncology, Kochi Medical School, Nankoku, Japan; 4. Department of Surgery, NHO Osaka National Hospital, Osaka, Japan

Source PDF DOI Publisher page
110 days

Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer

AuthorsNeal Shore; Nguyen; Barinder Kang; Amrita Sawhney; Clare Byrne; Jackson Tang; Magdaliz Gorritz; Chi-Chang Chen; Jeetvan Patel

Affiliations1. START Carolinas/Carolina Urologic Research Center, Myrtle Beach, USA; 2. Novartis Pharmaceuticals Corporation, East Hanover, USA; 3. Asclepius Analytics, New York, USA; 4. IQVIA, Wayne, USA

Source PDF DOI Publisher page
38 days

Japanese clinical practice guidelines for pharmacotherapy in older adults with cancer (second edition): an overview

AuthorsAyumu Matsuoka; Fumio Nagashima; Asao Ogawa; Hiroshi Yamamoto; Akira Katsumi; Naoko Hosono; Akitaka Makiyama; Tetsuya Hamaguchi; Junichi Nakazawa; Nagio Takigawa; Hajime Asahina; Masataka Sawaki; Akihiko Shimomura; Hiroyuki Nishiyama; Taigo Kato; Yuichi Ando

Affiliations1. Division of Survivorship Research, National Cancer Center Institute for Cancer Control, National Cancer Center, Tokyo, Japan; 2. Department of Medical Oncology, Faculty of Medicine, Kyorin University, Tokyo, Japan; 3. Division of Psycho-Oncology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan; 4. Department of Respiratory Medicine, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan; 5. Department of Hematology, National Center for Geriatrics and Gerontology, Obu, Japan; 6. Department of Hematology and Oncology, University of Fukui Hospital, Eiheiji, Japan; 7. Cancer Center, Gifu University Hospital, Gifu, Japan; 8. Department of Gastroenterological Medical Oncology and Medical Oncology, Saitama Medical University International Medical Center, Saitama, Japan; 9. Department of Medical Oncology, Kagoshima City Hospital, Kagoshima, Japan; 10. Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan; 11. Department of Respiratory Medicine, NHO Hokkaido Cancer Center, Sapporo, Japan; 12. Department of Breast Oncology, NHO Nagoya Medical Center, Nagoya, Japan; 13. Breast and Medical Oncology Department, NCGM - Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan; 14. Department of Urology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan; 15. Department of Urology, The University of Osaka Graduate School of Medicine, Osaka, Japan; 16. Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.